Titan Pharmaceuticals
TTNP
#10544
Rank
ยฃ4.6 M
Marketcap
ยฃ3.46
Share price
-3.76%
Change (1 day)
15.95%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2025 (TTM): -ยฃ3.38

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -ยฃ3.29. In 2023 the company made an earnings per share (EPS) of -ยฃ5.56 an increase over its 2022 EPS that were of -ยฃ11.40.

EPS history for Titan Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-ยฃ3.38
2023-ยฃ5.56-51.22%
2022-ยฃ11.40-15.61%
2021-ยฃ13.51-81.37%
2020-ยฃ72.49-77.52%
2019-ยฃ322.54-56.32%
2018-ยฃ738.44-59.51%
2017-ยฃ1,824-371.81%
2016ยฃ671.03-144.35%
2015-ยฃ1,513300%
2014-ยฃ378.22-121.54%
2013ยฃ1,756-151.38%
2012-ยฃ3,418-11.54%
2011-ยฃ3,863188.89%
2010-ยฃ1,337-10%
2009-ยฃ1,486
2007-ยฃ6,092-2.38%
2006-ยฃ6,241-39.13%
2005-ยฃ10,253-16.87%
2004-ยฃ12,333-22.43%
2003-ยฃ15,8994.9%
2002-ยฃ15,15661.9%
2001-ยฃ9,361-13.7%
2000-ยฃ10,84765.01%
1999-ยฃ6,574-35.87%
1998-ยฃ10,251-1824.71%
1997ยฃ594.35-102.4%
1996-ยฃ24,814

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
ยฃ6.56-299.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ5.27-259.91%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-ยฃ1.07-67.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
ยฃ0.69-120.96%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-ยฃ0.19-94.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-ยฃ2.92-11.39%๐Ÿ‡บ๐Ÿ‡ธ USA